Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children

Reps will promote Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children.

It will be used as an alternative or add-on to stimulants.

Kapvay is dosed once or twice daily like immediate-release clonidine. Kapvay has lower peak blood levels, which MIGHT reduce side effects...but this hasn't been proven.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote